Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges
Expert Opinion on Drug Safety April 15, 2022 Giordano Novak Rossi, Jaime E. C. Hallak, José Carlos Bouso Saiz et al. 24 citations
There were no serious AEs related to psilocybin and LSD administration. Most AEs were expected, manageable, and transient. Nevertheless, safety and tolerability concerns regarding some effects, such as dissociation, paranoia, and confusion, remain. Thus, randomized controlled trials with bigger samples are warranted to confirm their therapeutic effects and further investigate their safety and...